Taking A Look At CymaBay Therapeutics Inc (CBAY)’s Big Deal

CymaBay Therapeutics Inc (NASDAQ:CBAY) is running up on the news that it has scored an exclusive licensing agreement with Kowa Pharmaceuticals America, Inc.

Keep Reading →